Welcome to our dedicated page for MICROCHIP TECHNOLOGY SEC filings (Ticker: MCHPP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MICROCHIP TECHNOLOGY's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MICROCHIP TECHNOLOGY's regulatory disclosures and financial reporting.
MICROCHIP TECHNOLOGY INC (MCHP) reported that senior corporate vice president, worldwide client engagement, Joseph R. Krawczyk II acquired 41 shares of common stock on September 1, 2026 through the company’s 2001 Employee Stock Purchase Plan. Following this ESPP acquisition, he directly holds a total of 16,599 common shares.
MICROCHIP TECHNOLOGY INC (MCHP) executive Stephanus Duvenhage, Sr. Corp VP, Analog Business Unit, acquired 123 shares of common stock on September 1, 2026 through the Microchip Technology Incorporated 2001 Employee Stock Purchase Plan. The shares were bought at $60.6985 per share, bringing his direct holdings to 7,210 shares. No Rule 10b5-1 trading plan is reported.
MICROCHIP TECHNOLOGY INC (MCHP) reported that officer Mathew B. Bunker, Senior Corporate Vice President, Operations, acquired 53 shares of common stock on September 1, 2026 through a grant/award transaction. The shares were obtained under the company’s 2001 Employee Stock Purchase Plan in an exempt transaction and bring his direct holdings to 20,243 shares.
MICROCHIP TECHNOLOGY INC (MCHP) reported the initial equity holdings of Stephanus Duvenhage, Sr. Corp VP, Analog Business Unit, on a Form 3. He directly holds 7,087 shares of common stock and multiple restricted stock unit (RSU) awards, each representing a contingent right to receive one share of common stock, with vesting dates ranging from 2027 through 2030 contingent on continued service.
MICROCHIP TECHNOLOGY INC (MCHP) reported that executive Stephanus Duvenhage, Sr. Corp VP, Analog Business Unit, beneficially owns 7,087 shares of common stock directly. He also holds multiple awards of restricted stock units, each representing one share of common stock, with vesting dates from 2026 through 2029 contingent on continued service.
MICROCHIP TECHNOLOGY INC (MCHP) reported the initial equity holdings of officer Stephanus Duvenhage (Sr. Corp VP, Analog Business Unit) on a Form 3. He directly holds 7,087 shares of common stock, plus multiple tranches of Performance Stock Units (PSUs) and Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock. PSU awards cover various measurement periods tied to Microchip’s cumulative non-GAAP operating margin over 4–12 quarters, with target margins ranging from 25.0% to 42.0%. Earned PSUs and RSUs will vest on specified dates between 2027 and 2030, subject to continued service, and vested shares will be delivered upon vesting.
For MICROCHIP TECHNOLOGY INC (MCHP), reporting person Steve Sanghi reported the vesting and conversion of 28,853 Restricted Stock Units into an equal number of shares of common stock on August 15, 2026 at an exercise price of $80.26 per share. These shares were acquired as indirectly held through a trust and a family limited partnership. On the same date, 11,931 indirectly held common shares at $80.26 per share were delivered or withheld for payment of exercise price or tax liability. A related footnote states that the RSU grant will vest in four quarterly installments through February 15, 2027, subject to continued service, and clarifies that this amended Form 4 corrects the vesting date disclosure.
MICROCHIP TECHNOLOGY INC (MCHP) reported that Senior Corporate VP and CFO James Eric Bjornholt sold 4,112 shares of common stock on 2026-08-25 at $75.32 per share. The shares were held indirectly in a trust, and following the sale the trust holds 28,573 shares. The transaction was effected under a Rule 10b5-1 trading plan adopted on March 12, 2026.
MICROCHIP TECHNOLOGY INC (MCHP) reported amended insider transactions by Senior Corporate VP and CFO James Eric Bjornholt. On August 15, 2026, he exercised or converted restricted stock units and performance stock units into 3,021 shares of common stock at a conversion price of $80.26 per share, held indirectly through a trust. In related code F transactions, 1,296 shares of common stock were delivered or withheld for payment of exercise price or tax liability. Footnotes describe detailed RSU and PSU vesting schedules tied to cumulative non-GAAP operating margin over 12 quarters ending September 30, 2024, and state that this amended Form 4 corrects the performance measure date for the PSU grant.
MICROCHIP TECHNOLOGY INC (MCHP) reported insider equity activity by Senior Corporate VP and CFO James Eric Bjornholt on August 17, 2026. Restricted Stock Units covering 2,226 shares and Performance Stock Units covering 1,952 shares were exercised into common stock at a conversion price of $80.26 per share and held indirectly through a trust. In connection with these vestings, a total of 1,791 shares of common stock were delivered or withheld to cover the exercise price or tax obligations, including 837 shares explicitly identified as withheld to pay tax liability rather than sold.